Stay updated on Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page’s revision identifier was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a minor site/version update rather than a change to the underlying study information.
    Difference
    0.0%
    Check dated 2026-04-26T08:10:15.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. This appears to be a version bump with no changes to study details or user-facing information.
    Difference
    0.0%
    Check dated 2026-04-19T01:30:28.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    - Adds hepatocellular carcinoma as a topic on the page. Introduces a Genetic and Rare Diseases Information Center resource and updates the revision to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-21T08:45:15.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3; no study content or page functionality were altered.
    Difference
    0.0%
    Check dated 2026-03-06T19:27:02.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    The study record shows new update timestamps in January and February 2026. Older update entries from 2025 were removed, indicating refreshed page information.
    Difference
    0.1%
    Check dated 2026-02-20T15:29:40.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.1 to v3.4.2; no visible changes to study data, eligibility criteria, or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T07:31:57.000Z thumbnail image

Stay in the know with updates to Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial page.